Avenir Corp Pacira Bio Sciences, Inc. Transaction History

Avenir Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$41.31 - $52.16 $829,504 - $1.05 Million	-20,080 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $70,675 - $102,285	-2,570 Reduced 11.35%	20,080 $644,000
Q1 2018 May 14, 2018	BUY	$29.98 - $46.35 $203,264 - $314,253	6,780 Added 42.72%	22,650 $706,000
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $119,437 - $176,062	3,750 Added 30.94%	15,870 $724,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $74,970 - $82,950	2,100 Added 20.96%	12,120 $455,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,020	10,020 $478,000

257

48.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.12B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Avenir Corp, based on Form 13F filings with the SEC.

Stay updated on Avenir Corp with notifications on news.